Navigation Links
The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients
Date:5/22/2013

tients with such unmet medical needs, What makes this project even more exciting to support is that the technology was developed by Professor Sherie Morrison at UCLA while she was funded by a LLS Translational Research Grant.  LLS continues to find that funding through its research grant programs leads to discoveries that move on to biotechnology companies like Valor Biotherapeutics, LLC, who are more fully able to bring novel therapeutics to patients with blood cancer." 

Dr. Rahul Singhvi , chief executive officer of Valor Biotherapeutics, stated:  "We thank LLS for their commitment to our antibody-interferon fusion platform and their crucial financial support of the IGN002 program.  This funding represents a substantial investment in the development of IGN002 and will enable its development through Phase 1 clinical testing.  In addition, we welcome the opportunity to work with LLS and benefit from their vast experience in the lymphoma area as we advance IGN002 into clinical trials."

"IGN002 has demonstrated dramatic efficacy in rituximab-resistant preclinical models. The financial commitment by our JV partner, Caliber and the LLS will help in advancing this program to the proof-of-concept study in NHL patients.  Our R&D team is very excited to work with the LLS and Valor, to advance IGN002 to the clinic," said Sanjay D. Khare , Ph.D., president and CEO of ImmunGene, Inc. "This study will help us in understanding the utility of the technology for several other programs in the ImmunGene pipeline."

About The Leukemia & Lymphoma Society
The Leukemia & Lymphoma Society ® (LLS) is the world's largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. LLS fun
'/>"/>

SOURCE The Leukemia & Lymphoma Society
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Leading Leukemia Experts: High Leukemia Treatment Costs May Be Harming Patients
2. Tosedostat OPAL Study in Acute Myeloid Leukemia Published in Lancet Oncology
3. Launch Of Premium-priced, Novel Targeted Therapies Will Drive Growth In The Acute Leukemia Markets Beginning In 2015
4. The Leukemia & Lymphoma Society and Avella Specialty Pharmacy to Present Free Event on Oral Chemotherapy Drugs
5. Ambit and Astellas Announce Presentation of Results from Phase 2 ACE Study of Quizartinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) at the 54th Annual Meeting of the American Society of Hematology
6. Burlington Coat Factory Completes Another Record Year of Supporting The Leukemia & Lymphoma Society in its Quest to Beat Cancer
7. Ambit Biosciences Completes $50 Million Financing to Advance Lead Drug Candidate in Acute Myeloid Leukemia
8. Constellation Pharmaceuticals and The Leukemia & Lymphoma Society Partner to Develop Novel BET Inhibitor for the Treatment of Hematologic Malignancies
9. Actinium Pharmaceuticals Commences Screening for the Second Cohort of Patients in the Companys Ongoing Phase I/II Trial in Acute Myeloid Leukemia
10. Actinium Pharmaceuticals Announces The Addition of The Fred Hutchinson Cancer Research Center To Actiniums Multicenter Clinical Trial For Patients With Acute Myeloid Leukemia
11. Trovagene, Inc., Announces Issuance of U.S. Patent for NPM Mutants to Diagnose and Monitor Acute Myeloid Leukemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/4/2015)... BARCELONA , Spanje, July 4, 2015 ... SIR-Spheres® Y-90 harsmicrosferen aan eerstelijns chemotherapie voor ... de lever (mCRC) verlengt de progressievrije overleving ... met niet-resectabele, gemetastaseerde colorectale kanker (mCRC) die ... grootste verbetering gezien in progressievrije overleving (PFS) ...
(Date:7/3/2015)... HUATULCO , Mexique, July 3, 2015 /PRNewswire/ ... médicale continue cible les épidémies que sont l,hypertension, ... latine, par l,intermédiaire de plateformes éducatives gratuites et ...      (Photo: http://photos.prnewswire.com/prnh/20150630/227033 ) , ... le diabète en ligne , Prendre en ...
(Date:7/2/2015)... 3, 2015 Pharma Major ... de participación en ZAO "Biocom" en Rusia bajo ... incursión de Lupin en el mercado farmacéutico de ... ventas, colocándolo como uno de los 10 principales ... Durante más de una década, el mercado farmacéutico ...
Breaking Medicine Technology:Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 2Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 3Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 4Nieuwe SIRFLOX onderzoeksgegevens gepresenteerd op World Congress of Gastrointestinal Cancer 5Lutter contre trois maladies chroniques majeures en Amérique latine grâce à la formation médicale 2Lutter contre trois maladies chroniques majeures en Amérique latine grâce à la formation médicale 3Lupin adquiere Biocom en Rusia 2Lupin adquiere Biocom en Rusia 3
... N.J., Jan. 6, 2012  Tris Pharma, an emerging ... its core technology patent for its OralXR+™ platform. ... substantial estate filed by Tris Pharma and covers ... comprising drug-ion exchange resin complexes.  ...
... (Nasdaq: ENDP ) announced today it has ... BioDelivery Sciences International (Nasdaq: BDSI ) for ... transmucosal form of buprenorphine, a partial mu-opiate receptor agonist, ... is currently in phase III trials for the treatment ...
Cached Medicine Technology:Tris Pharma Announces US Patent Grant Covering Platform Technology 2Endo Pharmaceuticals and BioDelivery Sciences International Sign Licensing Agreement for BEMA Buprenorphine 2
(Date:7/6/2015)... Alameda County, CA (PRWEB) , ... July 06, ... ... Alameda County, CA area, Carlson & Associates has once again teamed up with ... funds helping homeless families to move toward self-sufficiency. FESCO was created especially to ...
(Date:7/6/2015)... , ... July 06, 2015 , ... In a split ... how to reduce their risk of having a fracture through the bone health screenings ... Awareness Day. , “We are participating because our residents need this information to remain ...
(Date:7/6/2015)... Georgia (PRWEB) , ... July 06, 2015 , ... ... has received nearly $400,000 in grant funds to support a three-year effort to ... , The work will be conducted in partnership with the Morehouse School of ...
(Date:7/6/2015)... Rockville, MD (PRWEB) , ... July 06, 2015 , ... ... MD, and Washington, DC, area patients. Kybella is a non-surgical method to ... the use of reducing moderate to severe fat deposits under the chin, commonly known ...
(Date:7/6/2015)... ... 06, 2015 , ... Orthopaedic & Spine Center ( http://www.OSC-Ortho.com ... SpineFrontier’s® PedFuse® REmind® Screws. The operation took place on Tuesday, June 30, 2015 ... an L5-S1 posterior lumbar interbody fusion on a 69 year old, male patient. ...
Breaking Medicine News(10 mins):Health News:Carlson & Associates Insurance Agency and Nonprofit Family Emergency Shelter Coalition (FESCO) Initiate New Charity Campaign in Alameda County, CA to Provide for Homeless 2Health News:Carlson & Associates Insurance Agency and Nonprofit Family Emergency Shelter Coalition (FESCO) Initiate New Charity Campaign in Alameda County, CA to Provide for Homeless 3Health News:National Bone Health Screening and Awareness Day 2Health News:Georgia State, Morehouse Partner To Tackle Diabetes, Heart Disease In Atlanta’s Minority Communities 2Health News:Rockville, MD Practice Now Offering New FDA-Approved Non-Surgical Double Chin Treatment 2Health News:100th Outpatient Less Exposure Surgery Procedure Completed by Industry Leading Surgeon Dr. Jeffrey Carlson 2Health News:100th Outpatient Less Exposure Surgery Procedure Completed by Industry Leading Surgeon Dr. Jeffrey Carlson 3
... to Improve Health: IOM-NAE Health Data Collegiate Challenge" was ... Academy of Engineering to promote interaction among future health ... harnessing new technologies and data to solve vexing health ... students studying engineering, computer science, and health disciplines to ...
... the human genetic code was mapped, expectations among scientists, health ... concerning the promise of genomics research for improving health. ... and bioethics experts cautions against the dangers of inflated expectations ... ways to avoid it while still realizing "the true ...
... Salamon HealthDay Reporter , THURSDAY, Feb. 17 (HealthDay ... weeks early has no discernible impact on babies, a new ... than their full-term peers and those delays may affect their ... term and 1,200 late preterm infants -- those born between ...
... FL (Feb. 17, 2011) -- The 2nd Annual National Women ... 6 at the Hyatt Regency Clearwater Beach, featuring two of ... country as speakers. Keynote speakers will be ... Department of Surgery Surgeon-in-Chief, The Johns Hopkins Hospital, and Nancy ...
... THURSDAY, Feb. 17 (HealthDay News) -- Some 709,000 youngsters aged ... liquor and other alcoholic beverages, a new federal study found. ... drinkers aren,t just getting a friend to buy a six ... liquor cabinet. Some are getting the alcohol directly from a ...
... -- The area of the brain responsible for visual reading ... is a "task machine" instead of a "sensory machine," according ... measured neural activity in eight blind people while they read ... activity in the exact same part of the brain (visual ...
Cached Medicine News:Health News:IOM and NAE launch collegiate challenge aimed at solving health problems 2Health News:Promise of genomics research needs a realistic view 2Health News:Delivery Even a Bit Early May Mean Developmental Delays 2Health News:Delivery Even a Bit Early May Mean Developmental Delays 3Health News:National career symposium offers strategic advice to attract, advance women in surgery 2Health News:Many Kids Who Drink Get Liquor From Home: Report 2Health News:Many Kids Who Drink Get Liquor From Home: Report 3
White Standard Girdle...
Below Knee Girdle, High Waist...
Bodyshaper For Men...
Torso Brief Bodysuit V-BA85...
Medicine Products: